Effects of synthetic pyroglutamyl-histidyl-proline-amide on serum levels of thyrotrophin, cortisol, growth hormone, insulin and PBI in normal subjects and patients with pituitary and thyroid disorders.
作者信息
Karlberg B, Almqvist S, Werner S
出版信息
Acta Endocrinol (Copenh). 1971 Jun;67(2):288-302. doi: 10.1530/acta.0.0670288.
PMID:4996103
Abstract
摘要
相似文献
1
Effects of synthetic pyroglutamyl-histidyl-proline-amide on serum levels of thyrotrophin, cortisol, growth hormone, insulin and PBI in normal subjects and patients with pituitary and thyroid disorders.
Acta Endocrinol (Copenh). 1971 Jun;67(2):288-302. doi: 10.1530/acta.0.0670288.
2
The effects of a synthetic thyrotrophin releasing hormone (TRH) in normal and endocrinopathic subjects.
Acta Endocrinol (Copenh). 1972 Oct;71(2):209-25. doi: 10.1530/acta.0.0710209.
3
Effects of synthetic thyrotropin-releasing hormone on plasma thyrotropin, growth hormone and insulin levels in man.
Endocrinol Jpn. 1971 Feb;17(6):101-8. doi: 10.1507/endocrj1954.18.101.
4
Effects of increasing doses of pyroglutamyl-histidyl-proline amide on serum thyrotrophin levels in normal subjects.
Acta Endocrinol (Copenh). 1972 May;70(1):196-208. doi: 10.1530/acta.0.0700196.
5
[Practical value of radioimmunoassay of pituitary thyreotropic hormone].
Ann Endocrinol (Paris). 1972 Nov-Dec;33(6):557-70.
6
Thyrotropin: alpha- and beta-subunits of thyrotropin, and prolactin responses to four-hour constant infusions of thyrotropin-releasing hormone in normal subjects and patients with pituitary-thyroid disorders.
J Clin Endocrinol Metab. 1979 Jul;49(1):127-31. doi: 10.1210/jcem-49-1-127.
7
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man.
Br Med J. 1970 May 2;2(5704):274-7. doi: 10.1136/bmj.2.5704.274.
8
[Investigations concerning the effect of synthetic "thyrotropin releasing factor" (TRF) in patients with thyroid gland function disorders and in healthy controls].
Acta Endocrinol Suppl (Copenh). 1971;152:76.
9
[Clinical investigation on human growth hormone secretion in hypothalamo-pituitary and thyroid diseases].
Nihon Naibunpi Gakkai Zasshi. 1969 Sep 20;45(6):645-54. doi: 10.1507/endocrine1927.45.6_645.
10
Thyrotrophin responses to intravenous thyrotrophin-releasing hormone in patients with hypothalamic and pituitary disease.
Clin Endocrinol (Oxf). 1974 Apr;3(2):113-22. doi: 10.1111/j.1365-2265.1974.tb01787.x.
引用本文的文献
1
Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.
J Clin Invest. 1973 Apr;52(4):783-8. doi: 10.1172/JCI107241.
2
[Plasma cortisol levels following intravenous injection of thyreotropin releasing hormone (TRH) in man].
Klin Wochenschr. 1972 Feb 15;50(4):211-2. doi: 10.1007/BF01487147.
3
Effect of TRH (thyrotropin-releasing hormone) on the fine structure and replication of TSH and prolactin cells in the rat.
Z Zellforsch Mikrosk Anat. 1973 Nov 23;145(1):23-37. doi: 10.1007/BF00307187.
4
Combined test for assessment of anterior pituitary function.
Br Med J. 1973 Nov 10;4(5888):326-9. doi: 10.1136/bmj.4.5888.326.
Zotero 插件